1. Is REDD1 a metabolic double agent? Lessons from physiology and pathology
   Florian A. Britto et al, 2020, American Journal of Physiology-Cell Physiology CrossRef
2. Sp1 Targeted PARP1 Inhibition Protects Cardiomyocytes From Myocardial Ischemia–Reperfusion Injury via Downregulation of Autophagy
   Yifeng Xu et al, 2021, Front. Cell Dev. Biol. CrossRef
3. Difluoromethylornithine attenuates isoproterenol-induced cardiac hypertrophy by regulating apoptosis, autophagy and the mitochondria-associated membranes pathway.
   Yu Zhao et al, 2021, Exp Ther Med CrossRef
4. NFIL3 Facilitates Neutrophil Autophagy, Neutrophil Extracellular Trap Formation and Inflammation During Gout via REDD1-Dependent mTOR Inactivation
   Honghu Tang et al, 2021, Front. Med. CrossRef
5. Blocking REDD1/TXNIP Complex Ameliorates HG-Induced Renal Tubular Epithelial Cell Apoptosis and EMT through Repressing Oxidative Stress
   Lin Mu et al, 2022, International Journal of Endocrinology CrossRef
6. Mechanisms driving fasting-induced protection from genotoxic injury in the small intestine
   Kali Deans-Fielder et al, 2024, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
7. DDIT4/mTOR signaling pathway mediates cantharidin-induced hepatotoxicity and cellular damage
   Wenchao Tang et al, 2024, Front. Pharmacol. CrossRef
8. Columbianadin Ameliorates Myocardial Injury by Inhibiting Autophagy Through the PI3K/Akt/mTOR Signaling Pathway in AMI Mice and Hypoxic H9c2 Cells
   Niu Zi‐Chang et al, 2024, Phytotherapy Research CrossRef